BackFidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Total Liabilities

Track Fidelity Select Biotechnology Portfolio's total liabilities ($1.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.13M
↓ 70.56% YoYΔ $-2.70M vs prior year quarter

Peer trimmed avg / median

Loading

Fidelity Select Biotechnology Portfolio Total Liabilities History

Loading

Fidelity Select Biotechnology Portfolio vs. peers: Total Liabilities Comparison

Loading

Fidelity Select Biotechnology Portfolio Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fidelity Select Biotechnology Portfolio (FBIOX) FAQ

The latest total liabilities for FBIOX is $1.1M as of September 2023. That compares with $3.8M in the prior-year period — down 70.6% year over year. Investors often review this figure alongside Fidelity Select Biotechnology Portfolio's historical trend and sector peers before judging valuation or financial health.

Over the past year, FBIOX's total liabilities moved from $3.8M to $1.1M — a 70.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fidelity Select Biotechnology Portfolio's operating scale or balance-sheet position.

A total liabilities figure of $1.1M for FBIOX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FBIOX's total liabilities ($1.1M), review year-over-year change from $3.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.